Skip to content
Inciteful Med
Resources About us Ask a Question

What Are the Red Flags of Vascular EDS (vEDS)?

Published: | Updated:

Generalized joint hypermobility alone is not a sign of Vascular EDS (vEDS). Genetic testing for vEDS is typically only necessary if you or a close family member have a history of major vascular events, such as arterial ruptures, spontaneous organ perforations, or unexplained early death.

Key Takeaways

  • • Generalized joint hypermobility is typically associated with Hypermobile EDS, not Vascular EDS.
  • • Major red flags for vEDS include early arterial tearing, spontaneous organ perforation, and a family history of sudden, unexplained early death.
  • • Minor physical signs of vEDS include profound translucent skin, severe unexplained hematomas, and hypermobility limited to small joints.
  • • Genetic testing for COL3A1 gene mutations is the definitive method to confirm or rule out Vascular EDS.

It is incredibly common for patients newly exploring an Ehlers-Danlos Syndrome (EDS) diagnosis to panic when they read about the severe risks associated with Vascular EDS (vEDS). If you have hypermobile joints, you may be wondering if you need a genetic test right away to rule out vEDS. The short answer is: typically, no. Genetic testing for vEDS is only ordered when specific, severe “red flags” are present in your medical or family history. Generalized joint hypermobility on its own is not a sign of vEDS [1].

Vascular EDS is a very rare and distinct genetic condition caused by mutations in the COL3A1 gene [2]. Unlike other forms of EDS that primarily affect joints and skin, vEDS is characterized by extreme fragility of the blood vessels and hollow organs [3]. Medical professionals use a set of major and minor criteria established in the 2017 International Classification for EDS to determine who should undergo genetic testing [4].

Major Red Flags for vEDS

The strongest indicators of vEDS are severe, life-threatening medical events that occur at a remarkably young age. If you or a first-degree relative have experienced any of the following, a genetic test is strongly recommended [5][6]:

  • Arterial rupture or dissection: Spontaneous tearing or bursting of a major blood vessel, usually before age 40 [7].
  • Spontaneous organ perforation: Unexplained bursting of a hollow organ, most commonly the sigmoid colon, without any underlying bowel disease [8].
  • Uterine rupture: Tearing of the uterus during the third trimester of pregnancy [9].
  • Carotid-cavernous sinus fistula: An abnormal connection between an artery and a vein behind the eye that happens without any physical trauma [10].
  • Family History: Having a family member already diagnosed with a known COL3A1 gene mutation, or a family history of sudden, unexplained death at a young age that could indicate an undiagnosed vascular event [2].

Minor Physical Signs

While major events are the clearest red flags, doctors also look for a combination of physical signs (minor criteria) that may raise suspicion. However, having one or two of these signs alone does not automatically mean you have vEDS [11].

  • Translucent skin: Skin that is unusually thin, allowing the underlying network of veins to be highly visible, particularly on the chest and abdomen [12]. (Note: Many people with hEDS naturally have pale skin and visible veins. In vEDS, this translucency is profound and widespread across the trunk.)
  • Severe, unexplained bruising: Bruising that happens easily, is severe, and takes a remarkably long time to heal [11]. (Note: Easy bruising is also very common in hEDS. However, bruising in vEDS is often extreme, sometimes involving massive, unexplained pooling of blood known as hematomas.)
  • Characteristic facial features: Some people with vEDS have a distinct facial structure, including thin lips (thin vermilion), a small chin (micrognathia), and prominent eyes [13].
  • Acrogeria: A prematurely aged appearance to the hands and feet, often looking thin and wrinkled [12].
  • Small joint hypermobility: Interestingly, while people with Hypermobile EDS (hEDS) have widespread joint looseness, hypermobility in vEDS is usually limited just to the small joints of the hands and feet (digits) [2].
  • Spontaneous pneumothorax: A collapsed lung that happens without trauma or underlying lung disease [14].

How vEDS Differs from Other EDS Subtypes

Understanding the differences between EDS subtypes can help alleviate the fear of a vEDS diagnosis. The 2017 classification system separates these types based on their clinical features and genetics [4][15].

  • Hypermobile EDS (hEDS): The most common type. It is characterized by widespread joint hypermobility, chronic pain, and associated issues like dysautonomia. It does not carry the high risk of spontaneous arterial or hollow-organ rupture seen in vEDS [1][11].
  • Classical EDS (cEDS): Defined by extreme skin hyperextensibility (stretchiness) and fragile skin that results in wide, thin, “cigarette-paper” scars. While vEDS skin is thin, it does not typically show these severe atrophic scars [16][17].
  • Classical-like EDS (clEDS): Similar to cEDS with velvety, stretchy skin and easy bruising, but lacks the severe atrophic scarring [18].
  • Spondylodysplastic EDS (spEDS): Primarily marked by skeletal abnormalities, such as severe scoliosis, short stature, and limb deformities [19][20].
  • Dermatosparaxis EDS (dEDS): Characterized by extremely fragile, severely sagging, and redundant skin, unlike the tight, translucent skin of vEDS [21][22].

Do I Need a Genetic Test?

Genetic testing via a connective tissue gene panel (next-generation sequencing) is the definitive “gold standard” to confirm or rule out vEDS [23][4]. However, testing is typically reserved for individuals presenting with unexplained, recurrent vascular events, organ ruptures, or a very strong combination of the minor physical traits [24][25].

If your primary symptoms are widespread joint hypermobility and pain, you most likely fit the profile for hEDS. A genetic test for vEDS is usually unnecessary unless a doctor identifies the specific red flags listed above [1]. If you do have a family history of young, sudden death or severe arterial tears, it is highly encouraged that you speak with a medical geneticist or a genetic counselor to determine if testing is right for you.

Frequently Asked Questions

Does having hypermobile joints mean I have Vascular EDS?
No, generalized joint hypermobility on its own is not a sign of Vascular EDS. While people with Hypermobile EDS have widespread joint looseness, hypermobility in vEDS is usually limited to the small joints of the hands and feet.
What are the major red flags that require vEDS testing?
The strongest indicators for testing are life-threatening medical events at a young age, such as a spontaneous arterial tear, unexplained bowel or organ perforation, uterine rupture during pregnancy, or a family history of sudden, unexplained early death.
What kind of bruising is typical in Vascular EDS?
Bruising in vEDS is often extreme and happens very easily. Unlike the small, frequent bruises common in standard hypermobility, vEDS bruising can involve massive, unexplained pooling of blood known as hematomas.
How is Vascular EDS formally diagnosed?
The definitive gold standard for diagnosing or ruling out vEDS is genetic testing through a connective tissue gene panel. This test specifically looks for mutations in the COL3A1 gene.

Questions for Your Doctor

  • • I know I have hypermobile joints, but I am feeling anxious about vEDS. Can we review my family history together to confirm whether I have any of the major red flags?
  • • Based on the type of bruising and skin features I have, do these fall into the typical range for hEDS, or do they warrant an evaluation by a genetic counselor?
  • • Are there any unexplained, sudden deaths or vascular events in my family history that you think justify a referral for a broader connective tissue gene panel?
  • • Since my hypermobility is widespread rather than limited to my small joints, can we confidently rule out the need for a COL3A1 genetic test at this time?

Questions for You

  • • Have any of my blood relatives experienced a spontaneous organ rupture, a severe arterial tear before age 40, or a sudden, unexplained early death?
  • • Is my hypermobility widespread throughout my major joints (which is typical of hEDS), or is it strictly limited to the small joints in my hands and feet?
  • • When I bruise, does it involve massive, unexplained pooling of blood (hematomas), or is it mostly just the small, frequent bruises on my legs that are common with standard hypermobility?
  • • What specifically triggered my anxiety about vEDS today — was it reading about the fatal risks online, or a new, specific physical symptom I've noticed?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Ehlers Danlos syndrome and gastrointestinal manifestations: a 20-year experience at Mayo Clinic.

    Nelson AD, Mouchli MA, Valentin N, et al.

    Neurogastroenterology and motility 2015; (27(11)):1657-66 doi:10.1111/nmo.12665.

    PMID: 26376608
  2. 2

    Vascular Ehlers-Danlos syndrome (vEDS): CT and histologic findings of pleural and lung parenchymal damage.

    Boussouar S, Benattia A, Escudié JB, et al.

    European radiology 2021; (31(8)):6275-6285 doi:10.1007/s00330-021-07710-6.

    PMID: 33651202
  3. 3

    Successful multidisciplinary management of vascular Ehlers-Danlos syndrome.

    Kanaka S, Yamada T, Matsuda A, et al.

    Clinical journal of gastroenterology 2022; (15(1)):146-150 doi:10.1007/s12328-021-01562-9.

    PMID: 34845584
  4. 4

    A multi-institutional experience in vascular Ehlers-Danlos syndrome diagnosis.

    Shalhub S, Byers PH, Hicks KL, et al.

    Journal of vascular surgery 2020; (71(1)):149-157 doi:10.1016/j.jvs.2019.04.487.

    PMID: 31353273
  5. 5

    Postmortem Identification of Vascular Ehlers-Danlos Syndrome in a Lung Transplant Recipient.

    Chhabria MS, You JY, Subramani MV, et al.

    Transplantation direct 2023; (9(6)):e1469 doi:10.1097/TXD.0000000000001469.

    PMID: 37197014
  6. 6

    Accuracy of Clinical Diagnostic Criteria for Patients With Vascular Ehlers-Danlos Syndrome in a Tertiary Referral Centre.

    Henneton P, Albuisson J, Adham S, et al.

    Circulation. Genomic and precision medicine 2019; (12(3)):e001996 doi:10.1161/CIRCGEN.117.001996.

    PMID: 30919682
  7. 7

    Ehlers-Danlos syndrome and the risk of spontaneous colonic perforation: clinical insights and surgical implications.

    Gaspar D, Pinheiro JL, Santos A, et al.

    Journal of surgical case reports 2025; (2025(7)):rjaf558 doi:10.1093/jscr/rjaf558.

    PMID: 40717702
  8. 8

    A case of sigmoid colon perforation due to segmental absence of intestinal musculature (SAIM) accompanied by vascular Ehlers-Danlos syndrome: a case report.

    Funaki K, Akagi T, Shiroshita H, et al.

    Surgical case reports 2023; (9(1)):138 doi:10.1186/s40792-023-01721-9.

    PMID: 37530898
  9. 9

    A 27-Year-Old Woman With Postpartum Papillary Muscle Rupture.

    Hutt E, Santos-Martins C, Aguilera J, et al.

    JACC. Case reports 2020; (2(14)):2191-2195 doi:10.1016/j.jaccas.2020.09.023.

    PMID: 34317136
  10. 10

    Cervical artery dissection: fibromuscular dysplasia versus vascular Ehlers-Danlos syndrome.

    Henrard C, Belge H, Fastré S, et al.

    Blood pressure 2019; (28(2)):139-143 doi:10.1080/08037051.2018.1557507.

    PMID: 30623691
  11. 11

    The dysmorphic phenotype in vascular Ehlers Danlos syndrome.

    Lyness JR, Morrison PJ

    Clinical dysmorphology 2023; (32(1)):1-6 doi:10.1097/MCD.0000000000000437.

    PMID: 36503916
  12. 12

    A case of vascular Ehlers-Danlos Syndrome with a cardiomyopathy and multi-system involvement.

    Lan NSR, Fietz M, Pachter N, et al.

    Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology 2018; (35()):48-51 doi:10.1016/j.carpath.2018.04.006.

    PMID: 29778910
  13. 13

    [Waxing and waning pulmonary nodules and cavities].

    Zhang T, Luo JM, Peng M, et al.

    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 2022; (45(5)):475-479 doi:10.3760/cma.j.cn112147-20211103-00768.

    PMID: 35527463
  14. 14

    Endovascular intervention to treat spontaneous carotid-cavernous fistula in a patient with Ehlers-Danlos Syndrome with an access site anatomical variant.

    See AJX, Ashok AH, Joshi Y, et al.

    BJR case reports 2024; (10(2)):uaae006 doi:10.1093/bjrcr/uaae006.

    PMID: 38433767
  15. 15

    A patient with a novel pathogenic variant in COL5A1 exhibiting prominent vascular and cardiac features.

    Lavanya K, Mahtani K, Abbott J, et al.

    American journal of medical genetics. Part A 2022; (188(7)):2192-2197 doi:10.1002/ajmg.a.62745.

    PMID: 35396906
  16. 16

    Ehlers- Danlos Syndrome.

    Basak P, Kanwar AJ, Kaur S, Nanda A

    Indian journal of dermatology, venereology and leprology 1989; (55(5)):324-326.

    PMID: 28128147
  17. 17

    Systemic manifestations of Ehlers-Danlos syndrome.

    Song B, Yeh P, Harrell J

    Proceedings (Baylor University. Medical Center) 2020; (34(1)):49-53 doi:10.1080/08998280.2020.1805714.

    PMID: 33456144
  18. 18

    The detailed obstetric course of the first Japanese patient with AEBP1-related Ehlers-Danlos syndrome (classical-like EDS, type 2).

    Sanai H, Nakamura Y, Koike Y, et al.

    The journal of obstetrics and gynaecology research 2023; (49(3)):1043-1047 doi:10.1111/jog.15541.

    PMID: 36600409
  19. 19

    Ehlers Danlos Syndrome with Glycosaminoglycan Abnormalities.

    Miyake N, Kosho T, Matsumoto N

    Advances in experimental medicine and biology 2021; (1348()):235-249 doi:10.1007/978-3-030-80614-9_10.

    PMID: 34807422
  20. 20

    Phenotype and response to growth hormone therapy in siblings with B4GALT7 deficiency.

    Sandler-Wilson C, Wambach JA, Marshall BA, et al.

    Bone 2019; (124()):14-21 doi:10.1016/j.bone.2019.03.029.

    PMID: 30914273
  21. 21

    Identification of an ADAMTS2 frameshift variant in a cat family with Ehlers-Danlos syndrome.

    Simon R, Kiener S, Thom N, et al.

    G3 (Bethesda, Md.) 2023; (13(9)) doi:10.1093/g3journal/jkad152.

    PMID: 37462293
  22. 22

    Pediatric Innominate Artery Pseudoaneurysm Rupture in Vascular Ehlers-Danlos Syndrome: A Case Report.

    Vos A, Burns KM

    Clinical practice and cases in emergency medicine 2021; (5(2)):226-229 doi:10.5811/cpcem.2021.3.51787.

    PMID: 34437011
  23. 23

    Identification of two novel COL3A1 variants in patients with vascular Ehlers-Danlos syndrome.

    Heo WY, Jang SY, Park TK, et al.

    Molecular genetics & genomic medicine 2023; (11(9)):e2240 doi:10.1002/mgg3.2240.

    PMID: 37461200
  24. 24

    Vascular Ehlers-Danlos syndrome in children: evaluating the importance of diagnosis and follow-up during childhood.

    Wilkinson NR, Cervi E, Wagner B, et al.

    European journal of human genetics : EJHG 2025; (33(3)):368-376 doi:10.1038/s41431-024-01773-x.

    PMID: 39730916
  25. 25

    Current Evidence and Future Perspectives in the Medical Management of Vascular Ehlers-Danlos Syndrome: Focus on Vascular Prevention.

    Buso G, Corvini F, Fusco EM, et al.

    Journal of clinical medicine 2024; (13(14)) doi:10.3390/jcm13144255.

    PMID: 39064294

This page provides educational information about the symptoms and red flags of Vascular EDS. It is not a substitute for professional medical advice, and you should always consult your healthcare provider or a genetic counselor regarding your individual risks.

Stay up to date

Get notified when new research about Ehlers Danlos Syndrome (EDS) is published.

No spam. Unsubscribe anytime.